Table 1. Characteristics of study patients (n=150).
Female † | 89 (59.3) |
Male | 61 (40.7) |
Age (years)** | 78 (72–83) |
Number of comorbidities* | 4 (2–5) |
Number of pre-admission medications* | 5 (3–7) |
Number of discharge medications* | 5 (3–7) |
Number of PPI prescriptions at discharge† | 80 (54) |
Pre-admission PPIs† ‡ | 66 (44) |
New PPI prescriptions during hospitalization† | 16 (20) |
PPI prescribed† | |
Omeprazole | 70 (87.5) |
Esomeprazole | 9 (11.2) |
Lansoprazole | 1 (1.2) |
Concurrent medications† | |
Aspirin | 32 (40) |
Aspirin plus clopidogrel | 4 (5) |
Clopidogrel | 3 (3.7) |
Corticosteroids | 3 (3.7) |
Warfarin | 3 (3.7) |
Heparin | 1 (1.2) |
Summaries reported as median (interquartile range).
Summaries reported as median (interquartile range).
Summaries reported as frequency (proportion).
Two pre-admission PPI prescriptions were discontinued during admission.